Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

Publisher： Karger

E-ISSN： 2235-3186|132|1|59-69

ISSN： 1660-8151

Source： Nephron, Vol.132, Iss.1, 2016-0, pp. : 59-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice

By  

Kidney and Blood Pressure Research, Vol. 41, Iss. 3, 2016-05 ,pp. : 311-324

Karger

Access to resources Recommend Favorite

Effect of an α-Adrenergic Blocker, and ACE Inhibitor and Hydrochlorothiazide on Blood Pressure and on Renal Function in Type 2 Diabetic Patients with Hypertension and Albuminuria

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 175-182

Karger

Access to resources Recommend Favorite

Renal Redox Stress and Remodeling in Metabolic Syndrome, Type 2 Diabetes mellitus, and Diabetic Nephropathy: Paying Homage to the Podocyte

By  

American Journal of Nephrology, Vol. 25, Iss. 6, 2005-10 ,pp. : 553-569

Karger

Access to resources Recommend Favorite

Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 44, Iss. 5, 2016-10 ,pp. : 339-353

Karger

Access to resources Recommend Favorite

Urinary Copper Excretion in Type 2 Diabetic Patients with Nephropathy

By  

Nephron, Vol. 88, Iss. 4, 2001-07 ,pp. : 307-312

Karger

Access to resources Recommend Favorite